Clinical efficacy and safety: cardiovascular system
The European Medicines Agency's scientific guidelines on the clinical evaluation of human medicines used in conditions affecting the cardiovascular system help medicine developers prepare marketing authorisation applications.
If you have comments on a document which is open for consultation, use the .
Please submit your comments to the following email address: firstname.lastname@example.org.
- Lipid disorders
- Pulmonary arterial hypertension
- Venous thromboembolism
- Heart failure
- Coronary artery disease (CAD)